欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/1444/001
药品名称Paclitaxel Accord 6 mg/ml
活性成分
    • paclitaxel 6.0 mg/ml
剂型Concentrate for solution for infusion
上市许可持有人Accord Healthcare Limited Winthontlaan 200 Utrecht Netherlands
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Luxembourg (LU)
    • Germany (DE)
      Paclitaxel Accord 6 mg/ml Konzentrat zur Herstellung einer Infusionlösung
    • Denmark (DK)
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Paclitaxel Accord 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
    • Lithuania (LT)
      Paclitaxel Accord 6 mg/ml koncentratas infuziniam tirpalui
    • Estonia (EE)
    • Hungary (HU)
      PACLITAXEL ACCORD 6 mg/ml koncentrátum oldatos infúzióhoz
    • Bulgaria (BG)
      Paclitaxel Accord
    • Cyprus (CY)
      PACLITAXEL ACCORD 6mg/ml CON. FOR SOL.FOR INFUSION
    • Romania (RO)
      Paclitaxel Accord 6 mg/ml concentrat pentru solutie perfuzabila
    • Slovakia (SK)
      Paclitaxel Accord 6mg/ml
    • Slovenia (SI)
许可日期2010/03/11
最近更新日期2024/02/26
药物ATC编码
    • L01CD01 paclitaxel
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase